The CXCR2 gene harbors multiple rare, missense variants that are associated with WBC, show signal in gene-level tests of association, and are represented on the Exome-Chip. 3 In addition, we ...

On 22 November, the US Food and Drug Administration (FDA) approved the first gene therapy for the genetic blood-clotting disorder haemophilia B — a one-time treatment that costs US$3.5 million ...